CN113925684A - Prevent special application of internal fistula infection - Google Patents
Prevent special application of internal fistula infection Download PDFInfo
- Publication number
- CN113925684A CN113925684A CN202111330378.4A CN202111330378A CN113925684A CN 113925684 A CN113925684 A CN 113925684A CN 202111330378 A CN202111330378 A CN 202111330378A CN 113925684 A CN113925684 A CN 113925684A
- Authority
- CN
- China
- Prior art keywords
- special application
- infection
- absorption pad
- internal fistula
- type
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010016717 Fistula Diseases 0.000 title claims abstract description 51
- 230000003890 fistula Effects 0.000 title claims abstract description 51
- 208000015181 infectious disease Diseases 0.000 title claims abstract description 45
- 238000010521 absorption reaction Methods 0.000 claims abstract description 54
- 239000003814 drug Substances 0.000 claims abstract description 37
- 239000000853 adhesive Substances 0.000 claims abstract description 24
- 230000001070 adhesive effect Effects 0.000 claims abstract description 24
- 229940079593 drug Drugs 0.000 claims abstract description 24
- 239000000463 material Substances 0.000 claims abstract description 21
- 230000002924 anti-infective effect Effects 0.000 claims abstract description 16
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 12
- 229960003333 chlorhexidine gluconate Drugs 0.000 claims abstract description 10
- YZIYKJHYYHPJIB-UUPCJSQJSA-N chlorhexidine gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.C1=CC(Cl)=CC=C1NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC1=CC=C(Cl)C=C1 YZIYKJHYYHPJIB-UUPCJSQJSA-N 0.000 claims abstract description 10
- 229920000742 Cotton Polymers 0.000 claims abstract description 8
- 239000003292 glue Substances 0.000 claims abstract description 6
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 229920006264 polyurethane film Polymers 0.000 claims description 5
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims description 3
- 229920002385 Sodium hyaluronate Polymers 0.000 claims description 3
- 229920002125 Sokalan® Polymers 0.000 claims description 3
- 229960001631 carbomer Drugs 0.000 claims description 3
- 150000004676 glycans Chemical class 0.000 claims description 3
- 239000001863 hydroxypropyl cellulose Substances 0.000 claims description 3
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims description 3
- 229920001282 polysaccharide Polymers 0.000 claims description 3
- 239000005017 polysaccharide Substances 0.000 claims description 3
- 229920002635 polyurethane Polymers 0.000 claims description 3
- 239000004814 polyurethane Substances 0.000 claims description 3
- 229940010747 sodium hyaluronate Drugs 0.000 claims description 3
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims description 3
- 230000002745 absorbent Effects 0.000 claims description 2
- 239000002250 absorbent Substances 0.000 claims description 2
- 238000001631 haemodialysis Methods 0.000 abstract description 25
- 230000000322 hemodialysis Effects 0.000 abstract description 25
- 238000011282 treatment Methods 0.000 abstract description 7
- 206010070834 Sensitisation Diseases 0.000 abstract description 6
- 230000008313 sensitization Effects 0.000 abstract description 6
- 230000000638 stimulation Effects 0.000 abstract description 6
- 230000002792 vascular Effects 0.000 abstract description 6
- 238000012423 maintenance Methods 0.000 abstract description 5
- 230000035699 permeability Effects 0.000 abstract 1
- 230000000474 nursing effect Effects 0.000 description 9
- 238000004806 packaging method and process Methods 0.000 description 6
- 206010003226 Arteriovenous fistula Diseases 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 4
- 229920000297 Rayon Polymers 0.000 description 4
- 241000700605 Viruses Species 0.000 description 4
- 210000004204 blood vessel Anatomy 0.000 description 4
- 238000004659 sterilization and disinfection Methods 0.000 description 4
- 230000004888 barrier function Effects 0.000 description 3
- 238000000502 dialysis Methods 0.000 description 3
- 239000000645 desinfectant Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010012434 Dermatitis allergic Diseases 0.000 description 1
- 235000009161 Espostoa lanata Nutrition 0.000 description 1
- 240000001624 Espostoa lanata Species 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 208000037815 bloodstream infection Diseases 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 238000010030 laminating Methods 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/02—Adhesive bandages or dressings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/00051—Accessories for dressings
- A61F13/00063—Accessories for dressings comprising medicaments or additives, e.g. odor control, PH control, debriding, antimicrobic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/01—Non-adhesive bandages or dressings
- A61F13/01034—Non-adhesive bandages or dressings characterised by a property
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/02—Adhesive bandages or dressings
- A61F13/0203—Adhesive bandages or dressings with fluid retention members
- A61F13/0206—Adhesive bandages or dressings with fluid retention members with absorbent fibrous layers, e.g. woven or non-woven absorbent pads or island dressings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/02—Adhesive bandages or dressings
- A61F13/0259—Adhesive bandages or dressings characterised by the release liner covering the skin adhering layer
- A61F13/0266—Adhesive bandages or dressings characterised by the release liner covering the skin adhering layer especially adapted for wound covering/occlusive dressings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/46—Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00361—Plasters
- A61F2013/00365—Plasters use
- A61F2013/0037—Plasters use for cosmesis
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Dermatology (AREA)
- Hematology (AREA)
- Materials Engineering (AREA)
- Epidemiology (AREA)
- External Artificial Organs (AREA)
Abstract
The invention provides a special application for preventing internal fistula infection, which is formed by sequentially sticking a layer of release paper, an anti-infection drug absorption pad, a sticky water-proof material and a glue back lining, wherein the anti-infection drug absorption pad and the water-proof material have the same size, and the sticky back lining is larger than the anti-infection drug absorption pad but smaller than the release paper. The anti-infection drug absorption pad is divided into a cotton pad absorption pad or a gel absorption pad, so that the type A special application and the type B special application are provided, and the type A special application and the type B special application respectively contain 2% of chlorhexidine gluconate, 5% of iodophor and 75% of alcohol, and the type A special application and the type B special application respectively have 3 types. The invention has reasonable design, is a disposable sterile external dressing, can be flatly stuck to the skin after use, has the characteristics of air permeability, good flexibility, low sensitization, low stimulation and less adhesive residue when being contacted with the skin, has moderate viscosity and is comfortable to use. Prevent that internal fistula puncture point from being infected, especially in the internal fistula maintenance of carrying the button hole puncture, guarantee the unblocked of this life line of hemodialysis patient's vascular access, guarantee hemodialysis patient's treatment.
Description
Technical Field
The invention belongs to medical dressings, relates to a special application for preventing internal fistula infection, is a disposable special application for a puncture point of an internal fistula of a hemodialysis patient, and is suitable for nursing of a vascular access of hemodialysis-a nursing of preventing infection of the puncture point of the internal fistula blood vessel.
Background
Hemodialysis is one of the major renal treatments for patients with renal failure. When a patient is dialyzed, a doctor firstly establishes a vascular access of the patient, then connects a pre-filled dialyzer and a vascular tube with the vascular access of the patient, and establishes extracorporeal circulation to start dialysis treatment. The blood vessel access comprises a central venous hemodialysis catheter and an arteriovenous internal fistula, and the arteriovenous internal fistula is the most commonly used blood vessel access and is a life line of a hemodialysis patient. Both AVF and AVG infections are reported in domestic and foreign literature to be a major clinical problem, often leading to increased hospitalization and mortality. KDOQI-2019 reports that the incidence of AVG infection of hemodialysis patients reaches 1.6-35%, and other studies show that the incidence of AVF infection reaches 11.7%, while the incidence of buttonhole puncture infection of AVF patients reaches 17%. The occurrence of infection is closely related to the maintenance of the internal fistula puncture point, and the current puncture point nursing only utilizes a cotton ball or common application.
The current nursing tool has serious defects in use: the application of 1 division of 3 or woundplasts is used in the nursing of patient's puncture point in hemodialysis process, but some patients of this kind of nursing instrument often take place skin allergy at present, cause internal fistula side skin itch even skin breakage, thereby cause the internal fistula to infect thereby influence the life of vascular access. After the hemodialysis of the patient and the nursing of dialysis interval at home to the point of puncture also have a lot of problems, patient oneself does not pay attention to on the one hand, and on the other hand does not have good nursing material to be used for the processing of point of puncture to lead to internal fistula infection to influence the life of internal fistula and even cause the patient to die.
Disclosure of Invention
The invention aims to provide a special application for preventing internal fistula infection, which is a special application for preventing infection and water, has no stimulation to skin and can not cause allergy. The special application of the invention is formed by sequentially laminating a layer of release paper, an anti-infection drug absorption pad, a water-proof material and a highly air-permeable semi-permeable adhesive backing. The anti-infection drug absorption pad and the waterproof material have the same size and are positioned in the middle of the release paper, and the diameter of the adhesive backing is larger than that of the anti-infection drug absorption pad and the waterproof material but smaller than that of the release paper.
The special application for preventing internal fistula infection is classified into a class A special application or a class B special application. The type A special application is a square application, and the infection-preventing medicine absorption pad is an infection-preventing medicine cotton piece absorption pad; the B-type special application is a round application, and the infection-preventing medicine absorption pad is an infection-preventing medicine gel absorption pad. The gel used for B type special application is carbomer or polysaccharides selected from cross-linked sodium hyaluronate or hydroxypropyl cellulose.
The water-proof material is polyurethane or EVA or TPU skin-friendly material.
The anti-infection drug absorption pad in the special application contains 2% of chlorhexidine gluconate, 5% of iodophor and 75% of alcohol, so that the A-class special application and the B-class special application have 3 types respectively, and can be selected according to the specific conditions of patients in clinic.
The 6 types of the application pastes are respectively and independently placed in an outer packaging bag for sterilization treatment so as to be convenient for clinical selection and use.
The special application of A class is used for protecting the puncture point of the internal fistula after puncture of the arteriovenous internal fistula and during hemodialysis interval, the applied absorption pad part is pasted on the puncture point of the internal fistula, the viscose back lining is larger than the absorption pad part and is flatly pasted on the skin around the puncture point, and the absorption pad is fixed. The absorbent pad of the cotton tablet containing 2% of chlorhexidine gluconate, 5% of iodophor and 75% of alcohol can be selected according to the requirement. The adhesive backing is made of a highly breathable semi-permeable polyurethane film, can effectively prevent water, bacteria and viruses and provide a safe sterile barrier, is an acrylic medical adhesive, has the characteristics of low sensitization, low stimulation and less residual glue, and has moderate viscosity and better patient experience comfort.
The B-type special application is used for protecting an internal fistula puncture point when the arteriovenous internal fistula puncture needle is pulled out after hemodialysis and during hemodialysis, and the applied absorption pad part is attached to the internal fistula puncture point; the adhesive backing is larger than the absorption pad part and is flatly stuck on the surrounding skin of the puncture point to fix the absorption pad. The medicinal gel absorption pad can be selected from gel absorption pad containing 2% chlorhexidine gluconate, 5% iodophor, and 75% alcohol as required. The adhesive backing can be made of a highly breathable semi-permeable polyurethane film, can effectively prevent water, bacteria and viruses and provide a safe sterile barrier, is an acrylic medical adhesive, has the characteristics of low sensitization, low stimulation and less residual adhesive, and has moderate viscosity and better patient experience comfort.
Because of the large individual difference of the skin, the anti-infection medicines selected by the invention are 2% of chlorhexidine gluconate, 5% of iodophor and 75% of alcohol respectively. The medical personnel can choose according to the skin characteristics of the patient.
Because the infection-preventing material selected by the invention is divided into two types according to the specific conditions of internal fistula of patients, one type is an infection-preventing cotton piece absorption pad (composed of anti-infective drugs and cotton pieces), and the other type is an infection-preventing gel absorption pad (composed of anti-infective drugs and gel).
The invention is a disposable sterile dressing for external use, which prevents the puncture point of the internal fistula of a patient from being infected by virus and bacteria and has the function of softening the crust of the puncture point. The blood vessel access of the hemodialysis patient is ensured, and the treatment of the hemodialysis patient is ensured. Especially, the internal fistula maintenance of the row buttonhole puncture can have better advantages. The special application for preventing infection of the internal fistula, which is designed by the product, is very simple, convenient and safe to use, and greatly reduces the chance of infection of the internal fistula. The invention has the following specific characteristics: (1) can play the prevention effect to the relevant blood stream infection that arteriovenous internal fistula puncture point arouses, reduce the incidence of arteriovenous internal fistula infection to prolong the life of arteriovenous internal fistula, guarantee hemodialysis patient's dialysis treatment. (2) Plays a role in protecting the internal fistula puncture point and improves the nursing quality of hemodialysis patients. (3) Reduce the hospitalization rate and medical cost of patients due to internal fistula infection. (4) Reduce the occurrence of allergic dermatitis of patients, and the skin around the puncture point is covered by the plaster to reduce the infection risk of the skin around the puncture point. (5) Providing comfort to the patient: the sterile dressing disclosed by the invention is reasonable in structural design, can be flatly pasted on skin after being used, is breathable and good in flexibility, is a highly breathable semi-permeable polyurethane film in contact with the skin, has the characteristics of low sensitization, low irritation and less adhesive residue, is moderate in viscosity, and is comfortable to use.
Drawings
Fig. 1 is a schematic structural view of the type a infection-preventing special application of the present invention.
Fig. 2 is a schematic structural view of the type B infection-preventing special application of the invention.
Detailed Description
Example 1
Referring to fig. 1, the disposable infection-preventing special application is a type-A special application and is a square application, and is formed by sequentially attaching a layer of release paper 1, an infection-preventing drug absorption pad 4, a water-blocking material 3 and a highly air-permeable semi-permeable adhesive backing 2, wherein the size of the infection-preventing drug absorption pad 4 and the size of the water-blocking material 3 are the same and are positioned in the middle of the release paper 1, and the diameter of the adhesive backing 2 is larger than that of the infection-preventing drug absorption pad and the water-blocking material 3 but smaller than that of the release paper 1. The viscose used for bonding is acrylic medical viscose, has the characteristics of low sensitization, low stimulation and less residual gum, and has moderate viscosity and better patient experience comfort.
The anti-infection drug absorption pad 4 of the A-type special application is a cotton piece absorption pad containing 2% of chlorhexidine gluconate, 5% of iodophor and 75% of alcohol respectively, so that the A-type special application has 3 types.
Referring to fig. 2, the type B special application is a circular application, and is formed by sequentially attaching a layer of release paper 1, an anti-infection drug gel absorption pad 4, a water-proof material 3 and a viscose back lining 2. The anti-infection drug absorption pad 4 and the waterproof material 3 are the same in size and are positioned in the middle of the release paper 1, and the diameter of the adhesive backing 2 is larger than that of the anti-infection drug absorption pad and the waterproof material 3 but smaller than that of the release paper 1.
The infection-preventing medicine absorption pad 4 of the B-type special application is a gel absorption pad containing 2% of chlorhexidine gluconate, 5% of iodophor and 75% of alcohol respectively, so that the B-type special application has 3 types. The gel used for B type special application is carbomer or polysaccharides selected from cross-linked sodium hyaluronate or hydroxypropyl cellulose.
The adhesive backing 2 of the A-type special application or the B-type special application can be a highly breathable semi-permeable polyurethane film, can effectively prevent water, bacteria and viruses, provides a safe sterile barrier, and has moderate viscosity and better patient experience comfort. The adhesive used for bonding is acrylic medical adhesive and has the characteristics of low sensitization, low stimulation and less residual adhesive. The water-proof material 3 is polyurethane or EVA or TPU.
And each type of the A type special application and the B type special application is separately placed in an outer packaging bag for sterilization treatment.
Example 2
Referring to fig. 1, the special application of class a is used for protecting the puncture point of the internal fistula after puncture of the arteriovenous internal fistula and during hemodialysis, and the drug absorption pad can be a cotton piece absorption pad containing 2% of chlorhexidine gluconate, 5% of iodophor and 75% of alcohol according to requirements. After the internal arteriovenous fistula puncture of hemodialysis succeeds or after the internal arteriovenous fistula puncture needle of hemodialysis is pulled out, an external packaging bag of the patch of the invention A is opened according to clinical requirements, the patch is taken out, the release paper 1 is aseptically peeled, the medicine absorption pad 4 is partially attached to the puncture point of the internal fistula, and then the adhesive backing 2 exceeding the absorption pad part is flatly attached to the skin around the puncture point for fixation. Secondly, in the hemodialysis interval, when a patient has puncture point pollution or maintenance of buttonhole puncture points needs to use the patch due to various reasons, the limbs on the side of the internal fistula are cleaned and wiped dry, disinfection is carried out by iodophor or alcohol and other disinfectant for drying, then an external packaging bag of the patch of the type A patch is opened, the patch is taken out, the release paper 1 is peeled off in an aseptic mode, the applied medicine absorption pad 4 is partially attached to the puncture point of the internal fistula, and then the adhesive backing 2 exceeding the absorption pad is flatly attached to the skin around the puncture point for fixation, so that the operation of the type A patch is completed.
Referring to fig. 2, the B-type special application is used for protecting the puncture point of the internal fistula when the arteriovenous internal fistula puncture needle is pulled out after hemodialysis and during hemodialysis, and the medicinal gel absorption pad can be selected from gel absorption pads respectively containing 2% of chlorhexidine gluconate, 5% of iodophor and 75% of alcohol. After the internal arteriovenous fistula puncture of hemodialysis succeeds or after the internal arteriovenous fistula puncture needle of hemodialysis is pulled out, opening an external packaging bag of one application in the B-class application, taking out the application, aseptically peeling off the release paper 1, attaching part of the applied medicine absorption pad 4 to the puncture point of the internal fistula, and then flatly attaching the part of the adhesive backing 2, which exceeds the absorption pad, to the skin around the puncture point for fixation. Secondly, in the hemodialysis interval, when a patient is polluted by puncture points or maintenance of buttonhole puncture points needs to use the patch due to various reasons, the limbs on the side of the internal fistula are cleaned and wiped dry, disinfection is carried out by using disinfectant such as iodophor or alcohol for drying, then an external packaging bag of the patch of the type B patch is opened, the patch is taken out, the release paper 1 is peeled off in an aseptic mode, the applied medicine absorption pad 4 is partially attached to the puncture points of the internal fistula, and then the adhesive backing 2 exceeding the absorption pad is flatly attached to the skin around the puncture points for fixation. And finishing the operation of B-type application.
Claims (7)
1. The utility model provides a prevent special application of internal fistula infection which characterized in that, in proper order by the one deck from type paper (1), prevent infecting medicine absorption pad (4), glue water proof material (3), glue backing (2) paste and constitute, prevent infecting medicine absorption pad (4), water proof material (3) and glue backing (2), water proof material (3) are located from type paper (1) middle part, prevent infecting medicine absorption pad (4) and water proof material (3) size the same, glue backing (2) are greater than prevent infecting medicine absorption pad (4) but are less than from type paper (1).
2. The special application for preventing internal fistula infection as claimed in claim 1, wherein the special application for preventing internal fistula infection is classified into a class A special application and a class B special application, wherein the class A special application is a square application, the infection-preventing drug absorption pad (4) of the special application is an infection-preventing drug cotton piece absorption pad, the class B special application is a round application, and the infection-preventing drug absorption pad (4) of the special application is an infection-preventing drug gel absorption pad.
3. The special application for preventing internal fistula infection as set forth in claim 1, wherein the anti-infective drug absorbent pad (4) contains 2% chlorhexidine gluconate, 5% iodophor, and 75% alcohol, respectively, so that each of the type a and type B special applications has 3 types.
4. The special application for preventing internal fistula infection as set forth in claim 1, wherein the water-barrier material (3) is selected from polyurethane, EVA or TPU.
5. The special application for preventing internal fistula infection as set forth in claim 1, wherein the adhesive backing (2) is a highly breathable semi-permeable polyurethane film.
6. The special application for preventing internal fistula infection as set forth in claim 1, wherein the adhesive used for adhesion is an acrylic medical adhesive.
7. The special application for preventing internal fistula infection as claimed in claim 1, wherein the gel used in the class B special application is carbomer or polysaccharide selected from cross-linked sodium hyaluronate or hydroxypropyl cellulose.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111330378.4A CN113925684A (en) | 2021-11-11 | 2021-11-11 | Prevent special application of internal fistula infection |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111330378.4A CN113925684A (en) | 2021-11-11 | 2021-11-11 | Prevent special application of internal fistula infection |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN113925684A true CN113925684A (en) | 2022-01-14 |
Family
ID=79286151
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202111330378.4A Pending CN113925684A (en) | 2021-11-11 | 2021-11-11 | Prevent special application of internal fistula infection |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN113925684A (en) |
Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN201578445U (en) * | 2009-12-22 | 2010-09-15 | 刘香君 | Woundplast with medical stone powder |
| CN103190986A (en) * | 2013-03-13 | 2013-07-10 | 上海嘉乐股份有限公司 | Woundplast not sticking to wound |
| CN104162193A (en) * | 2014-08-08 | 2014-11-26 | 浙江大学 | Disposable application special for dialysis indwelling catheter |
| CN106726145A (en) * | 2016-12-29 | 2017-05-31 | 芜湖研高粘胶新材料有限公司 | A kind of sterilized adhesive bandage |
| CN206381207U (en) * | 2016-10-10 | 2017-08-08 | 郭玉萍 | A kind of medical application |
| CN107854218A (en) * | 2017-12-12 | 2018-03-30 | 成都美益达医疗科技有限公司 | A kind of disposable hydrocolloid antibacterial application |
| CN209154217U (en) * | 2018-10-25 | 2019-07-26 | 南京林业大学 | A kind of new medical hydrogel combine dressing |
| CN213607447U (en) * | 2020-10-26 | 2021-07-06 | 贵州中医药大学 | Hemostatic medicine plaster |
| CN217040502U (en) * | 2021-11-11 | 2022-07-26 | 浙江大学 | Prevent special application of internal fistula infection |
-
2021
- 2021-11-11 CN CN202111330378.4A patent/CN113925684A/en active Pending
Patent Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN201578445U (en) * | 2009-12-22 | 2010-09-15 | 刘香君 | Woundplast with medical stone powder |
| CN103190986A (en) * | 2013-03-13 | 2013-07-10 | 上海嘉乐股份有限公司 | Woundplast not sticking to wound |
| CN104162193A (en) * | 2014-08-08 | 2014-11-26 | 浙江大学 | Disposable application special for dialysis indwelling catheter |
| CN206381207U (en) * | 2016-10-10 | 2017-08-08 | 郭玉萍 | A kind of medical application |
| CN106726145A (en) * | 2016-12-29 | 2017-05-31 | 芜湖研高粘胶新材料有限公司 | A kind of sterilized adhesive bandage |
| CN107854218A (en) * | 2017-12-12 | 2018-03-30 | 成都美益达医疗科技有限公司 | A kind of disposable hydrocolloid antibacterial application |
| CN209154217U (en) * | 2018-10-25 | 2019-07-26 | 南京林业大学 | A kind of new medical hydrogel combine dressing |
| CN213607447U (en) * | 2020-10-26 | 2021-07-06 | 贵州中医药大学 | Hemostatic medicine plaster |
| CN217040502U (en) * | 2021-11-11 | 2022-07-26 | 浙江大学 | Prevent special application of internal fistula infection |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2797451B1 (en) | Post surgical breast dressing | |
| CN109998778B (en) | Medical application suit with pressure | |
| CN217040502U (en) | Prevent special application of internal fistula infection | |
| CN111407919B (en) | Chitosan quaternary ammonium salt sterilization gauze and preparation method thereof | |
| CN102247629A (en) | Disposable hemodialysis nursing bag | |
| CN209107788U (en) | A kind of hemostatic dressing plaster | |
| CN113925684A (en) | Prevent special application of internal fistula infection | |
| CN207591088U (en) | Internal jugular vein temporary catheter fixing plaster for hemodialysis | |
| CN210644327U (en) | Emergency bandage | |
| CN207237018U (en) | A kind of haemodialysis treatment towel | |
| CN215020452U (en) | Incision dressing | |
| CN105343983B (en) | Dialysis catheter protective cover | |
| CN216603268U (en) | Arm dialysis is with hemostasis is applied ointment or plaster | |
| CN205181475U (en) | Novel medical treatment is with combination package | |
| CN216417518U (en) | Special pad pasting of prevention and treatment PICC pipe infection | |
| CN111956859B (en) | Antibacterial hemostatic band-aid containing traditional Chinese medicine components and preparation method thereof | |
| CN203042644U (en) | Aloe wound paste | |
| CN215915478U (en) | Central venous catheter dressing change bag | |
| CN221751140U (en) | Efficient antibacterial medical wound application | |
| CN217409147U (en) | But compound waterproof navel subsides of reuse | |
| CN220124962U (en) | Wound nursing device | |
| CN211460847U (en) | Intravenous indwelling infusion patch for infant umbilical hernia nursing | |
| CN220967513U (en) | Anti-adhesion antibacterial dressing with multilayer structure | |
| CN219763441U (en) | Anti-infection hemostatic patch | |
| CN217138456U (en) | Waterproof medical adhesive plaster with convenient trauma nursing window |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |